STAT3 and neoplasm: Our results demonstrate that combining CpG-Stat3 siRNA with CTLA4 or PD-1 antibody suppressed A20 lymphoma tumor growth more effectively than either CpG-Stat3 siRNA or CTLA4 or PD-1 antibody alone.